<DOC>
	<DOCNO>NCT02906176</DOCNO>
	<brief_summary>A clinical trail investigate influence SLCO2B1 polymorphism pharmacokinetic characteristic voriconazole CYP2C19 poor metabolizers</brief_summary>
	<brief_title>Influence SLCO2B1 Polymorphism PK Voriconazole CYP2C19 PM</brief_title>
	<detailed_description />
	<mesh_term>Voriconazole</mesh_term>
	<criteria>Healthy male volunteer CYP2C19 Poor metabolizer rs3781727 SNP wild variant genotype History clinically significant respiratory , cardiovascular , renal , hepatic , hematologic , neurological disorder</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>